(Circulation. 2008;117:1856-1863.)
© 2008 American Heart Association, Inc.
Molecular Cardiology |
From the Department of Cardiac and Vascular Sciences, St Georges University of London, London, UK (G.F.); Department of Cardiology, Medical University of Innsbruck, Innsbruck, Austria (B.M.); and Cardiovascular Division, Kings College London, London, UK (Y.H., Q. Xiao, Q. Xu).
Correspondence to Professor Qingbo Xu, Cardiovascular Division, The James Black Centre, Kings College London, 125 Coldharbour Lane, London SE5 9NU, UK. E-mail qingbo.xu{at}kcl.ac.uk
Received October 12, 2007; accepted February 12, 2008.
Background— Recently, it has been shown that stem/progenitor cells may repair damaged/lost endothelial cells in vein grafts and wire-injured arteries. In the present study, we investigated endothelial cell turnover and regeneration in apolipoprotein E (apoE)–/–/transgenic mice carrying LacZ genes driven by an endothelial TIE2 promoter.
Methods and Results— To assess cell proliferation on the surface of aortas in apoE–/– mice and wild-type controls, BrdU was injected into the tail vein and labeled on en face preparation. BrdU-positive cells on the aortas were observed occasionally in wild-type mice and frequently at sites prone to lesion development in apoE–/– mice (0.18±0.1% versus 1.12±0.2%; P<0.001). Endothelial integrity tests demonstrated that the areas with high rate of cell turnover displayed Evans blue leakage, low levels of VE-cadherin expression, and increased cell attachment, as evidenced by Evans blue dye injection, immunostaining, and scanning electron microscopy, respectively. Furthermore, immunostaining for CD34, Sca-1, Flk-1, and CD133 indicated that
3% to 5% of total cells on the aorta were positive in apoE–/– mice. En face double labeling using Ki-67 and progenitor markers revealed that 30% to 50% of progenitor+ cells expressed Ki-67, indicating a state of proliferation. To clarify the origin of endothelial progenitor cells participating in endothelial repair in apoE–/– mice, a chimeric mouse model was created by bone marrow transplantation between apoE–/– and LacZ+/+/apoE–/– mice. Ten months after bone marrow transplantation,
3% to 4% of total cells in the lesion-prone areas were β-gal positive in apoE–/– with apoE–/–/TIE2-LacZ bone marrow mice. When cells of aortas from chimeric mice were cultivated on Matrigel-coated plates, a capillary-like structure was found, which showed β-gal/CD31 or β-gal/von Willebrand factor double positivity. By a combined analysis of laser dissection microscopy and nest reverse transcription polymerase chain reaction, it was found that β-gal+ cells were mainly expressing CD31 and CD144.
Conclusions— Our findings provide the first quantitative data on endothelial turnover and repair by progenitor cells that are, at least in part, derived from bone marrow during development of atherosclerosis in apoE–/– mice.
Related Article:
This article has been cited by other articles:
![]() |
A. Zampetaki, L. Zeng, A. Margariti, Q. Xiao, H. Li, Z. Zhang, A. E. Pepe, G. Wang, O. Habi, E. deFalco, et al. Histone Deacetylase 3 Is Critical in Endothelial Survival and Atherosclerosis Development in Response to Disturbed Flow Circulation, January 5, 2010; 121(1): 132 - 142. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. C. Laxton, Y. Hu, J. Duchene, F. Zhang, Z. Zhang, K.-Y. Leung, Q. Xiao, R. S. Scotland, C. P. Hodgkinson, K. Smith, et al. A Role of Matrix Metalloproteinase-8 in Atherosclerosis Circ. Res., October 23, 2009; 105(9): 921 - 929. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Thorin and N. Thorin-Trescases Vascular endothelial ageing, heartbeat after heartbeat Cardiovasc Res, October 1, 2009; 84(1): 24 - 32. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Y. Foo, E. R. Heller, J. Wykrzykowska, C. J. Sullivan, J. J. Manning-Tobin, K. J. Moore, R. E. Gerszten, and A. Rosenzweig Vascular effects of a low-carbohydrate high-protein diet PNAS, September 8, 2009; 106(36): 15418 - 15423. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Sanz, P. R. Moreno, and V. Fuster The Year in Atherothrombosis J. Am. Coll. Cardiol., April 14, 2009; 53(15): 1326 - 1337. [Full Text] [PDF] |
||||
![]() |
Y. Matsumoto, V. Adams, C. Walther, C. Kleinecke, P. Brugger, A. Linke, T. Walther, F. W. Mohr, and G. Schuler Reduced number and function of endothelial progenitor cells in patients with aortic valve stenosis: a novel concept for valvular endothelial cell repair Eur. Heart J., February 1, 2009; 30(3): 346 - 355. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Pirro, F. Bagaglia, L. Paoletti, R. Razzi, and M. R. Mannarino Review: Hypercholesterolemia-associated endothelial progenitor cell dysfunction Therapeutic Advances in Cardiovascular Disease, October 1, 2008; 2(5): 329 - 339. [Abstract] [PDF] |
||||
![]() |
A. Schober and C. Weber Leptin and EPCs in Arterial Injury: Yes, We Can! Circ. Res., August 29, 2008; 103(5): 447 - 449. [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2008 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |